TGFB1 and diabetic kidney disease: Studies on the pathogenesis of VASH-1 in DKD have reported that VASH-1 has a potential therapeutic effect on early DKD fibrosis by inhibiting TGFβ1 levels in renal tissues of type 1 diabetic mice (Sato, 2013).